Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
It is said old is gold. True indeed! As a case in point, a 150-year-old drug has gained prominence as a potential cancer therapy in the future to bring in much relief to cancer patients. Recently, researchers from the Ohio State University in the USA have found that the drug called Papaverine could make tumours more...
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
